The report analyzes and forecasts the anti-infective drugs market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of anti-infective drugs, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major anti-infective drugs companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of anti-infective drugs upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of anti-infective drugs and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global anti-infective drugs market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the anti-infective drugs market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of anti-infective drugs market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Key players operating in the global anti-infective drugs market are Merck & Co., Inc., Bayer AG, Pfizer, Inc., Gilead Sciences, GlaxoSmithKline plc, Novartis AG, Bristol-Myers Squibb, Sanofi, Allergen plc, F. Hoffman-La Roche Ltd., and Johnson and Johnson, among others.
The global anti-infective drugs market has been segmented as follows:
Global Anti-infective Drugs Market, by Type
Global Anti-infective Drugs Market, by Indication
Global Anti-infective Drugs Market, by Distribution Channel
Global Anti-infective Drugs Market, by Region
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Acronyms Used
2.3. Research Methodology
3. Executive Summary
3.1. Global Anti-infective Drugs Market Snapshot
3.2. Market Opportunity Map
4. Market Overview
4.1. Product Overview
4.2. Global Anti-infective Drugs Market Size (US$ Mn) Forecast, 2017–2026
4.3. Global Anti-infective Drugs Market Outlook
4.4. Key Industry Developments
5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Key Trends
5.6. Porter’s Analysis
5.7. Pipeline Analysis
5.8. Disease Prevalence
5.9. Key Brand Analysis
6. Global Anti-infective Drugs Market Analysis, by Type
6.1. Key Findings
6.2. Introduction
6.3. Anti-infective Drugs Market Value Share Analysis, by Type
6.4. Anti-infective Drugs Market Forecast, by Type
6.4.1. Global Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
6.4.1.1. B - Lactams
6.4.1.2. Quinolones
6.4.1.3. Macrolides
6.4.1.4. Tetracycline
6.4.1.5. Aminoglycoside
6.4.1.6. Others (Sulfonamide, Phenicols)
6.4.2. Global Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
6.4.2.1. Azoles
6.4.2.2. Echinocandins
6.4.2.3. Polyenes
6.4.2.4. Others
6.4.3. Global Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
6.5. Anti-infective Drugs Market Analysis, by Type
6.6. Anti-infective Drugs Market Attractiveness Analysis, by Type
6.7. Market Trends
7. Anti-infective Drugs Market Analysis, by Disease Indication
7.1. Key Findings
7.2. Introduction
7.3. Anti-infective Drugs Market Value Share Analysis, by Disease Indication
7.4. Anti-infective Drugs Market Forecast, by Disease Indication
7.4.1. Pneumonia
7.4.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
7.4.3. Sepsis
7.4.4. Tuberculosis
7.4.5. Dermatophytosis
7.4.6. Aspergillosis
7.4.7. Candidiasis
7.4.8. Hepatitis Virus Infection
7.4.9. HIV Infection
7.4.10. Respiratory Virus Infection
7.4.11. Others
7.5. Anti-infective Drugs Market Analysis, by Disease Indication
7.6. Anti-infective Drugs Market Attractiveness Analysis, by Disease Indication
7.7. Key Trends
8. Anti-infective Drugs Market Analysis, by Distribution Channel
8.1. Key Findings
8.2. Introduction
8.3. Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
8.4. Anti-infective Drugs Market Forecast, by Distribution Channel
8.4.1. Hospital Pharmacy
8.4.2. Retail Pharmacy
8.4.3. Online Sales
8.5. Anti-infective Drugs Market Analysis, by Distribution Channel
8.6. Anti-infective Drugs Market Attractiveness Analysis, by Distribution Channel
8.7. Market Trends
9. Anti-infective Drugs Market Analysis, by Region
9.1. Global Market Scenario
9.2. Anti-infective Drugs Market Value Share Analysis, by Region
9.3. Anti-infective Drugs Market Forecast, by Region
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Anti-infective Drugs Market Attractiveness Analysis, by Region
10. North America Anti-infective Drugs Market Analysis
10.1. Key Findings
10.2. North America Anti-infective Drugs Market Overview
10.3. North America Anti-infective Drugs Market Value Share Analysis, by Country
10.4. North America Anti-infective Drugs Market Forecast, by Country
10.4.1. U.S.
10.4.2. Canada
10.5. North America Anti-infective Drugs Market Value Share Analysis, by Type
10.6. North America Anti-infective Drugs Market Forecast, by Type
10.6.1. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
10.6.2. North America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
10.6.2.1. B - Lactams
10.6.2.2. Quinolones
10.6.2.3. Macrolides
10.6.2.4. Tetracycline
10.6.2.5. Aminoglycoside
10.6.2.6. Others (Sulfonamide, Phenicols)
10.6.3. North America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
10.6.4. North America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
10.6.4.1. Azoles
10.6.4.2. Echinocandins
10.6.4.3. Polyenes
10.6.4.4. Others
10.6.5. North America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
10.7. North America Anti-infective Drugs Market Value Share Analysis, by Indication
10.8. North America Anti-infective Drugs Market Forecast, by Indication
10.8.1. Pneumonia
10.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
10.8.3. Sepsis
10.8.4. Tuberculosis
10.8.5. Dermatophytosis
10.8.6. Aspergillosis
10.8.7. Candidiasis
10.8.8. Hepatitis Virus Infection
10.8.9. HIV Infection
10.8.10. Respiratory Virus Infection
10.8.11. Others
10.9. North America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
10.10. North America Anti-infective Drugs Market Forecast, by Distribution Channel
10.10.1. Hospital Pharmacy
10.10.2. Retail Pharmacy
10.10.3. Online Sales
10.11. North America Anti-infective Drugs Market Attractiveness Analysis
11. Europe Anti-infective Drugs Market Analysis
11.1. Key Findings
11.2. Europe Anti-infective Drugs Market Overview
11.3. Europe Anti-infective Drugs Market Value Share Analysis, by Country
11.4. Europe Anti-infective Drugs Market Forecast, by Country
11.4.1. U.K.
11.4.2. Germany
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest of Europe
11.5. Europe Anti-infective Drugs Market Value Share Analysis, by Type
11.6. Europe Anti-infective Drugs Market Forecast, by Type
11.6.1. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
11.6.2. Europe Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
11.6.2.1. B - Lactams
11.6.2.2. Quinolones
11.6.2.3. Macrolides
11.6.2.4. Tetracycline
11.6.2.5. Aminoglycoside
11.6.2.6. Others (Sulfonamide, Phenicols)
11.6.3. Europe Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
11.6.4. Europe Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
11.6.4.1. Azoles
11.6.4.2. Echinocandins
11.6.4.3. Polyenes
11.6.4.4. Others
11.6.5. Europe Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
11.7. Europe Anti-infective Drugs Market Value Share Analysis, by Indication
11.8. Europe Anti-infective Drugs Market Forecast, by Indication
11.8.1. Pneumonia
11.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
11.8.3. Sepsis
11.8.4. Tuberculosis
11.8.5. Dermatophytosis
11.8.6. Aspergillosis
11.8.7. Candidiasis
11.8.8. Hepatitis Virus Infection
11.8.9. HIV Infection
11.8.10. Respiratory Virus Infection
11.8.11. Others
11.9. Europe Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
11.10. Europe Anti-infective Drugs Market Forecast, by Distribution Channel
11.10.1. Hospital Pharmacy
11.10.2. Retail Pharmacy
11.10.3. Online Sales
11.11. Europe Anti-infective Drugs Market Attractiveness Analysis
12. Asia Pacific Anti-infective Drugs Market Analysis
12.1. Key Findings
12.2. Asia Pacific Anti-infective Drugs Market Overview
12.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Country
12.4. Asia Pacific rope Anti-infective Drugs Market Forecast, by Country
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of APAC
12.5. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type
12.6. Asia Pacific Anti-infective Drugs Market Forecast, by Type
12.6.1. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
12.6.2. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
12.6.2.1. B - Lactams
12.6.2.2. Quinolones
12.6.2.3. Macrolides
12.6.2.4. Tetracycline
12.6.2.5. Aminoglycoside
12.6.2.6. Others (Sulfonamide, Phenicols)
12.6.3. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
12.6.4. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
12.6.4.1. Azoles
12.6.4.2. Echinocandins
12.6.4.3. Polyenes
12.6.4.4. Others
12.6.5. Asia Pacific Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
12.7. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Indication
12.8. Asia Pacific Anti-infective Drugs Market Forecast, by Indication
12.8.1. Pneumonia
12.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
12.8.3. Sepsis
12.8.4. Tuberculosis
12.8.5. Dermatophytosis
12.8.6. Aspergillosis
12.8.7. Candidiasis
12.8.8. Hepatitis Virus Infection
12.8.9. HIV Infection
12.8.10. Respiratory Virus Infection
12.8.11. Others
12.9. Asia Pacific Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
12.10. Asia Pacific Anti-infective Drugs Market Forecast, by Distribution Channel
12.10.1. Hospital Pharmacy
12.10.2. Retail Pharmacy
12.10.3. Online Sales
12.11. Asia Pacific Anti-infective Drugs Market Attractiveness Analysis
13. Latin America Anti-infective Drugs Market Analysis
13.1. Key Findings
13.2. Latin America Anti-infective Drugs Market Overview
13.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Country
13.4. Latin America Anti-infective Drugs Market Forecast, by Country
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of LATAM
13.5. Latin America Anti-infective Drugs Market Value Share Analysis, by Type
13.6. Latin America Anti-infective Drugs Market Forecast, by Type
13.6.1. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
13.6.2. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
13.6.2.1. B - Lactams
13.6.2.2. Quinolones
13.6.2.3. Macrolides
13.6.2.4. Tetracycline
13.6.2.5. Aminoglycoside
13.6.2.6. Others (Sulfonamide, Phenicols)
13.6.3. Latin America Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
13.6.4. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
13.6.4.1. Azoles
13.6.4.2. Echinocandins
13.6.4.3. Polyenes
13.6.4.4. Others
13.6.5. Latin America Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
13.7. Latin America Anti-infective Drugs Market Value Share Analysis, by Indication
13.8. Latin America Anti-infective Drugs Market Forecast, by Indication
13.8.1. Pneumonia
13.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
13.8.3. Sepsis
13.8.4. Tuberculosis
13.8.5. Dermatophytosis
13.8.6. Aspergillosis
13.8.7. Candidiasis
13.8.8. Hepatitis Virus Infection
13.8.9. HIV Infection
13.8.10. Respiratory Virus Infection
13.8.11. Others
13.9. Latin America Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
13.10. Latin America Anti-infective Drugs Market Forecast, by Distribution Channel
13.10.1. Hospital Pharmacy
13.10.2. Retail Pharmacy
13.10.3. Online Sales
13.11. Latin America Anti-infective Drugs Market Attractiveness Analysis
14. Middle East & Africa Anti-infective Drugs Market Analysis
14.1. Key Findings
14.2. Middle East & Africa Anti-infective Drugs Market Overview
14.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Country
14.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Country
14.4.1. GCC Countries
14.4.2. South Africa
14.4.3. Rest of MEA
14.5. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type
14.6. Middle East & Africa Anti-infective Drugs Market Forecast, by Type
14.6.1. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-bacterial Drugs
14.6.2. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-bacterial Drugs
14.6.2.1. B - Lactams
14.6.2.2. Quinolones
14.6.2.3. Macrolides
14.6.2.4. Tetracycline
14.6.2.5. Aminoglycoside
14.6.2.6. Others (Sulfonamide, Phenicols)
14.6.3. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Type - Anti-fungal Drugs
14.6.4. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-fungal Drugs
14.6.4.1. Azoles
14.6.4.2. Echinocandins
14.6.4.3. Polyenes
14.6.4.4. Others
14.6.5. Middle East & Africa Anti-infective Drugs Market Forecast, by Type - Anti-viral Drugs
14.7. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Indication
14.8. Middle East & Africa Anti-infective Drugs Market Forecast, by Indication
14.8.1. Pneumonia
14.8.2. Methicillin-resistant Staphylococcus Aureus (MRSA)
14.8.3. Sepsis
14.8.4. Tuberculosis
14.8.5. Dermatophytosis
14.8.6. Aspergillosis
14.8.7. Candidiasis
14.8.8. Hepatitis Virus Infection
14.8.9. HIV Infection
14.8.10. Respiratory Virus Infection
14.8.11. Others
14.9. Middle East & Africa Anti-infective Drugs Market Value Share Analysis, by Distribution Channel
14.9.1. Hospital Pharmacy
14.9.2. Retail Pharmacy
14.9.3. Online Sales
14.10. Middle East & Africa Anti-infective Drugs Market Forecast, by Distribution Channel
14.11. Middle East & Africa Anti-infective Drugs Market Attractiveness Analysis
15. Competition Matrix
15.1. Anti-infective Drugs Market Share Analysis, by Company, 2016
15.2. Company Profiles
15.2.1. Merck & Co., Inc.
15.2.1.1. Company Profiles
15.2.1.2. Business Overview
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.3. Bayer AG
15.3.1.1. Company Profiles
15.3.1.2. Business Overview
15.3.1.3. Strategic Overview
15.3.1.4. SWOT Analysis
15.4. Pfizer, Inc.
15.4.1.1. Company Profiles
15.4.1.2. Business Overview
15.4.1.3. Strategic Overview
15.4.1.4. SWOT Analysis
15.5. Gilead Sciences
15.5.1.1. Company Profiles
15.5.1.2. Business Overview
15.5.1.3. Strategic Overview
15.5.1.4. SWOT Analysis
15.6. GlaxoSmithKline plc
15.6.1.1. Company Profiles
15.6.1.2. Business Overview
15.6.1.3. Strategic Overview
15.6.1.4. SWOT Analysis
15.7. Novartis AG
15.7.1.1. Company Profiles
15.7.1.2. Business Overview
15.7.1.3. Strategic Overview
15.7.1.4. SWOT Analysis
15.8. Bristol-Myers Squibb Co
15.8.1.1. Company Profiles
15.8.1.2. Business Overview
15.8.1.3. Strategic Overview
15.8.1.4. SWOT Analysis
15.9. Sanofi
15.9.1.1. Company Profiles
15.9.1.2. Business Overview
15.9.1.3. Strategic Overview
15.9.1.4. SWOT Analysis
15.10. Allergen plc
15.10.1.1. Company Profiles
15.10.1.2. Business Overview
15.10.1.3. Strategic Overview
15.10.1.4. SWOT Analysis
15.11. F. Hoffman-La Roche Ltd.
15.11.1.1. Company Profiles
15.11.1.2. Business Overview
15.11.1.3. Strategic Overview
15.11.1.4. SWOT Analysis
15.12. Johnson and Johnson
15.12.1.1. Company Profiles
15.12.1.2. Business Overview
15.12.1.3. Strategic Overview
15.12.1.4. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers